Comparing platelet rich plasma and corticosteroids for hip osteoarthritis pain relief
Official title: The Efficacy of Platelet Rich Plasma Compared With Corticosteroid Injections for the Treatment of Pain Associated With Hip Osteoarthritis
Run by LifeBridge Health · NCT06793982 · Data updated 2026-11-12
This study is testing whether platelet rich plasma injections work better than corticosteroid injections to relieve pain and improve function in people with hip osteoarthritis.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years to 80 Years |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | LifeBridge Health Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | February 21, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06793982 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 21-80 with a radiographic diagnosis of Kellgren-Lawrence grade II or III hip osteoarthritis who require an injection for symptom relief.
✕Probably not a fit
Patients with chronic pain conditions, recent hip injections, or those with diabetes mellitus may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center randomized trial that aims to compare the effectiveness of platelet rich plasma (PRP) injections versus corticosteroid injections in alleviating pain and improving function in patients with hip osteoarthritis. The study will assess patient-reported outcomes to determine which treatment offers superior relief. Participants will be randomly assigned to receive either PRP or corticosteroid injections, and their progress will be monitored throughout the study duration.
Why it matters
Potential benefit: If successful, this study could provide patients with a more effective treatment option for managing hip osteoarthritis pain.
How similar studies have gone: While there is limited evidence comparing these two treatments in a randomized manner, the use of platelet rich plasma has shown promise in other studies, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 21-80 years * Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthritis * Indicated for a Hip injection to treat Hip OA symptoms Exclusion Criteria: * Any injections into the target Hip within three months * Current overlying skin infection * Current or previous diagnosis of "chronic pain" * Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.) * Allergy to any potential ingredients or medications utilized in any of the two groups * Treatment with another investigational drug or other intervention for pain * Diagnosis of Diabetes Mellitus * If female, pregnant or planning to be pregnant within the following 3 months or study duration * Any condition(s) or diagnosis, both physical or psychological, or physical exam finding in the opinion of the investigator that would precludes participation
Where it's running
-
Sinai Hospital of Baltimore
Baltimore, Maryland, United States Recruiting
Study contacts
- Study coordinator: Martin Gesheff, DHSc
- Email: mgesheff@lifebridgehealth.org
- Phone: 410-601-9467
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
Preoperative Fasting to Shape the Gut with Hip Replacement
This trial tests whether a 20-day preoperative fasting plan can lower inflammatory signals and broaden gut microbes in adults undergoing total hip arthroplasty.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Spinal anesthesia with intrathecal morphine vs PENG block (with or without dexamethasone) for hip replacement
In people aged 60 and older undergoing total hip arthroplasty, this study tests whether three anesthesia approaches provide better pain control and fewer side effects: spinal with intrathecal morphine, spinal with a PENG block, or spinal with a PENG block plus dexamethasone.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.